SUMMARY -We present an isolate of Klebsiella pneumoniae OXA-48 isolated in a 68-year-old man who underwent radical prostatectomy due to prostate cancer. Th e antibiotic susceptibility testing to a wide range of antibiotics was performed by disk diff usion method and determination of minimal inhibitory concentrations. Th e isolate was classifi ed as multidrug-resistant. It showed intermediate susceptibility to imipenem and meropenem, resistance to ertapenem, and sensitivity only to colistin, amikacin, and trimethoprim-sulfamethoxazole. Th e isolate was positive for ESBLs, negative for AmpC. Polymerase chain reaction and sequencing revealed bla , bla CTX-M-15 and bla . Th e plasmid encoding OXA-48 ß-lactamase did not belong to any known PCR-based replicon typing. According to genotyping, the isolate belonged to ST37.
Introduction
Carbapenems are the drugs of choice for the treatment of infections caused by multiresistant gram-negative bacilli 1 . Carbapenemases involved in acquired resistance belong to Ambler class A serin ß-lactamases (KPC, SME, GES, IMI, NMC), class B metallo-ß--lactamases (MBL) of IMP, VIM or NDM family, or OXA-48-like ß-lactamases belonging to class D ß-lactamases 2 . Resistance phenotypes of carbapenemase producing Enterobacteriaceae (CRE) range from extreme multiresistance to resistance only to ß-lactams 2 . Th e fi rst carbapenem-resistant Enterobacteriacae species in Croatia was NDM-1 producing Klebsiella (K.) pneumoniae isolated in 2008 at the Zagreb University Hospital Center 3 . Later on, in 2011, a KPC-2-positive K. pneumoniae was isolated at the same institution 4 . Th is observation gave rise to a multicenter study on carbapenem-resistance in Enterobacteriaceae in Croatia, conducted in 2011-2012, which revealed the predominance of VIM-1 ß-lactamase in two large hospital centers (Zagreb and Split), but only KPC ß-lactamase was reported at Sestre milosrdnice University Hospital Center 5 . In 2013, an outbreak of VIM-1 producing Enterobacter (E.) cloacae was reported at Split University Hospital Center 6 . Following emergence of KPC ß-lactamases in 2013, the fi rst outbreak associated with KPC-2 was observed at Sestre milosrdnice University Hospital Center in 2014 7 . Carbapenemaseproducing Enterobacteriacae were further identifi ed in Sestre milosrdnice University Hospital Center, posing serious therapeutic problem for the clinicians.
Carbapenemase producing Enterobacteriaceae often co-harbor resistance genes encoding extended-spectrum ß-lactamases (ESBLs), plasmid-mediated AmpC ß-lactamases and qnr genes responsible for reduced susceptibility to fl uoroqinolones 2 . Sestre milosrdnice University Hospital Center is a hospital with 1200 beds in all medical specialties. It serves a great part of the Zagreb population and acts as a referral hospital for the whole Croatia for specifi c patients/procedure groups, thus covering a catchment population of about 4,000,000 people.
Case Report
A 68-year-old man without serious illnesses in his medical history and no prior hospitalization in other hospitals was admitted for the fi rst time to Department of Urology, Sestre milosrdnice University Hospital Center, for elevated prostate specifi c antigen (PSA) level. During his fi rst hospitalization, transrectal ultrasound guided prostate biopsy was performed. After biopsy, the patient experienced no discomfort or dysuria. His diuresis was regular and he was discharged home while expecting his histopathologic report. Th e antibiotic ciprofl oxacin was prescribed one day prior to biopsy and for the next fi ve days. Th e dosage was 500 mg two times daily. No urine cultures were performed prior to biopsy, as the patient reported no symptoms related to urinary tract infection.
Histopathologic fi nding revealed prostatic cancer and the patient was admitted for the second time. Radical prostatectomy was performed. Th e procedure was routine, with no complications. One hour prior to surgery, the patient received a single dose of 750 mg of cefuroxime. Since no fever was present during his stay at the Department and his routine urine culture sampled at admission was sterile, no further antibiotics were administered.
Two weeks after discharge from the hospital, the patient presented to the Department due to obstructive voiding symptoms. No dysuria or fever was present, so a Foley catheter was placed. One week after catheter placement, it was removed and the patient reported normal urine voiding. Abdominal ultrasound found no residual urine after voiding.
One month after surgical treatment, the patient was admitted to the Department as an emergency case. His diagnosis upon admission was as follows: urinary retention caused by urinary tract infection. Immediately upon admission to the same Department, his urine was sampled for microbiological analysis. Th e specimen was sent to Department of Microbiology, Parasitology and Hospital Infections, Sestre milosrdnice University Hospital Center and processed. Urine culture revealed K. pneumoniae in the quantity of 10 5 . According to the zone diameter breakpoint in disk diffusion method, the K. pneumoniae isolate was resistant to the following antibiotics: ampicillin, amoxicillinclavulanic acid, piperacillin-tazobactam, cefazolin, cefuroxime iv., ceftibuten, cefi xime, ceftriaxone, ceftazidime, cefepime, ertapenem, norfl oxacin, levofl oxacin, ciprofl oxacin, and gentamicin. It was susceptible to amikacin, trimethoprim-sulfamethoxazole and colistin (susceptibility to colistin was determined by Etest). Th e isolate showed intermediate susceptibility to imipenem and meropenem. Th e isolate of K. pneumoniae was sent to the Zagreb University Hospital Center for further investigation and OXA-48 ß-lactamase was identifi ed.
Trimethoprim-sulfamethoxazole per os was administered. Urethrocystoscopy was done to exclude mechanical obstruction (e.g., bladder-urethra anastomosis sclerozation or bladder calculi) as the cause of urinary retention. No obstruction was found. Upon completion of antibiotic therapy, the patient had no residual urine after voiding, no pain during voiding, and was fully continent, suggesting a conclusion that urinary tract infection was the cause of urinary retention.
Hospital infection control measures were recommended, including isolation of the patient, cleaning of the ward and equipment, hygienic measures, use of gloves and gowns by medical personnel, etc.
Methods

Identifi cation and antimicrobial susceptibility testing
Th e isolate of K. pneumoniae was identifi ed using standard biochemical methods. Th e antibiotic susceptibility testing to a wide range of antibiotics was performed by disk diff usion method and broth microdilution method in 96-well microtiter plates and inter-preted according to the Clinical and Laboratory Standards Institute (CLSI) breakpoints [8] [9] [10] . Th e isolate was classifi ed as multidrug-resistant, extensively-drug-resistant or pan-drug-resistant according to Magiorakis et al. 11 .
Phenotypic tests for detection of ESBLs, plasmidmediated AmpC ß-lactamases and carbapenemases
Double disk synergy test (DDST) 12 and CLSI combined disk test with the addition of clavulanic acid 10 were performed to detect ESBLs. Plasmid-mediated AmpC ß-lactamases were detected by combined disk test using cephalosporin disks combined with PBA (3-aminophenylboronic acid) 13 . Modifi ed Hodge test (MHT) was used to screen for the production of carbapenemases 14 . Additionally, the isolate was tested by combined disk tests with imipenem and meropenem alone and combined with 3-aminophenylboronic acid test (PBA), 0.1 M EDTA or both to screen for KPC, MBLs, or simultaneous production of KPC and MBL, respectively 15, 16 .
Conjugation
Th e transferability of meropenem resistance was determined by conjugation (broth mating method) employing E. coli A15R -strain resistant to rifampicin and E. coli J65 resistant to sodium azide 17 . Transconjugant was selected on combined plates containing meropenem (1 mg/L) to inhibit the growth of recipient strain and rifampicin (256 mg/L) or sodium azide (100 mg/L) to suppress donor strains.
Molecular detection of resistance genes
Th e genes conferring resistance to ß-lactams including broad spectrum and extended-spectrum ß-lactamases (bla SHV , bla TEM , bla CTX-M and bla PER-1 ) [18] [19] [20] [21] [22] , plasmid-mediated AmpC ß-lactamases 23 , class A carbapenemases (bla KPC , bla SME , bla IMI and bla NMC ,) [24] [25] [26] , class B (bla VIM, bla IMP and bla NDM ) [27] [28] [29] , and carbapenem hydrolyzing oxacillinases (bla OXA-48 ) 30 and to fl uoroquinolones (qnrA, qnrB and qnrS) 31 were determined by PCR using protocols and conditions as described previously. Th e DNA was extracted by boiling method. Amplicons were column-purifi ed with Qiagen DNA purifi cation kit (Inel, Zagreb, Croatia) and sequenced directly in Eurofi n sequencing service (Ebersberg, Germany).
Characterization of plasmids
Plasmids were extracted with Qiagen Mini kit according to the manufacturer's instructions. PCR-based replicon typing (PBRT) according to Carattoli et al. 32 was applied to type the resistance plasmids carrying carbapenemase genes.
Genotyping
Th e isolate was also genotyped by MSLT according to Diancourt et al. 33 .
Results
Antimicrobial susceptibility testing
Determination of minimal inhibitory concentrations (MICs) revealed resistance to amoxicillin alone and combined with clavulanic acid, piperacillin, piperacillin/tazobactam, cefazolin, cefuroxime, ceftazidime, cefotaxime and cefepime with MIC of >128 mg/L, ertapenem (16 mg/L), gentamicin (>128 mg/L) and ciprofl oxacin (32 mg/L), as shown in Table 1 . Meropenem and imipenem showed intermediate susceptibility (2 mg/L). 
Conjugation
Th e K. pneumoniae isolate did not transfer meropenem resistance to E. coli recipient strain.
Molecular detection of resistance genes
Polymerase chain reaction and sequencing revealed bla , bla CTX-M-15 and bla SHV-11 with the latter being chromosomally encoded in K. pneumoniae.
Characterization of plasmids
Th e plasmid encoding OXA-48 ß-lactamase did not belong to any known PBRT.
Genotyping
Th e isolate belonged to ST37.
Discussion
We report a case of urinary tract infection in a patient with prostate cancer associated with K. pneumoniae positive for OXA-48 ß-lactamase. OXA-48 was fi rst reported in Turkey in 2001 30, 34 36, 40 . Laboratory detection of OXA-48 ß-lactamase poses a serious problem because of the low level carbapenem resistance and sometimes lack of additional ESBL. In our report, the strain had elevated carbapenem MICs co-harbored CTX-M-15 ß-lactamase, which is responsible for resistance to expanded-spectrum cephalosporins. Th e majority of OXA-48 producing European isolates coproduce CTX-M-15 or SHV-12 ß-lactamase 38 . OXA-48 ß-lactamase is usually plasmid-mediated and the majority of plasmids encoding it belong to W, P or L/M incompatibility group 2, 38 . Transposon Tn1999 is responsible for the mobilization of bla OXA-48 gene 36 . However, our isolate did not transfer resistance to E. coli recipient strain and the plasmid extraction did not yield any product in PCR for plasmid incompatibility typing. PCR for qnr genes was negative indicating that fl uoroquinolone resistance was probably due to other mechanism such as mutations in gyrA or parC genes.
Microbiological laboratories should be able to detect and characterize carbapenemase producing Enterobacteriaceae in order to prevent the spread of these important 'superbugs'.
